{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:34:13Z","timestamp":1788986053435,"version":"build-2803163510"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32AI007641-17"],"award-info":[{"award-number":["5T32AI007641-17"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DA042720"],"award-info":[{"award-number":["K24DA042720"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25DA033211"],"award-info":[{"award-number":["R25DA033211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Persons who use drugs (PWUD) face substantial risk of Staphylococcus aureus infections. Limited data exist describing clinical and substance use characteristics of PWUD with invasive S. aureus infections or comparing treatment and mortality outcomes in PWUD vs non-PWUD. These are needed to inform optimal care for this marginalized population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We identified adults hospitalized from 2013 to 2018 at 2 medical centers in San Francisco with S. aureus bacteremia or International Classification of Diseases\u2013coded diagnoses of endocarditis, epidural abscess, or vertebral osteomyelitis with compatible culture. In addition to demographic and clinical characteristic comparison, we constructed multivariate Cox proportional hazards models for 1-year infection-related readmission and mortality, adjusted for age, race\/ethnicity, housing, comorbidities, and methicillin-resistant S. aureus (MRSA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 963 hospitalizations for S. aureus infections in 946 patients, 372 of 963 (39%) occurred in PWUD. Among PWUD, heroin (198\/372 [53%]) and methamphetamine use (185\/372 [50%]) were common. Among 214 individuals using opioids, 98 of 214 (46%) did not receive methadone or buprenorphine. PWUD had lower antibiotic completion than non-PWUD (70% vs 87%; P\u2005&amp;lt;\u2005.001). While drug use was not associated with increased mortality, 1-year readmission for ongoing or recurrent infection was double in PWUD vs non-PWUD (28% vs 14%; adjusted hazard ratio [aHR], 2.0 [95% confidence interval {CI}: 1.3\u20132.9]). MRSA was independently associated with 1-year readmission for infection (aHR, 1.5 [95% CI: 1.1\u20132.2]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Compared to non-PWUD, PWUD with invasive S. aureus infections had lower rates of antibiotic completion and twice the risk of infection persistence\/recurrence at 1 year. Among PWUD, both opioid and stimulant use were common. Models for combined treatment of substance use disorders and infections, particularly MRSA, are needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab367","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T20:00:52Z","timestamp":1619208052000},"page":"263-270","source":"Crossref","is-referenced-by-count":22,"title":["Comparative 1-Year Outcomes of Invasive <i>Staphylococcus aureus<\/i> Infections Among Persons With and Without Drug Use: An Observational Cohort Study"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-5954","authenticated-orcid":false,"given":"Ayesha","family":"Appa","sequence":"first","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Adamo","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephenie","family":"Le","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Davis","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Winston","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B","family":"Doernberg","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Chambers","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Martin","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy K","family":"Hills","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip O","family":"Coffin","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"},{"name":"San Francisco Department of Public Health, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jain","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"2022012912322404400_CIT0001","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002\u20132013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022012912322404400_CIT0002","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2022012912322404400_CIT0003","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections from 2002 to 2012","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"2022012912322404400_CIT0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use\u2013 associated infective endocarditis and heart valve surgery, 2007 to 2017","volume":"170","author":"Schranz","year":"2018","journal-title":"Ann Intern Med"},{"key":"2022012912322404400_CIT0005","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial infections associated with substance use disorders, large cohort of United States hospitals, 2012\u20132017","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0006","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"N Engl J Med"},{"key":"2022012912322404400_CIT0007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.15585\/mmwr.mm6722a2","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among persons who inject drugs\u2014six sites, 2005\u20132016","volume":"67","author":"Jackson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022012912322404400_CIT0008","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"2022012912322404400_CIT0009","doi-asserted-by":"crossref","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0010","doi-asserted-by":"crossref","first-page":"e0225460","DOI":"10.1371\/journal.pone.0225460","article-title":"Mortality, morbidity, and cardiac surgery in injection drug use (IDU)-associated versus non-IDU infective endocarditis: the need to expand substance use disorder treatment and harm reduction services","volume":"14","author":"Thakarar","year":"2019","journal-title":"PLoS One"},{"key":"2022012912322404400_CIT0011","doi-asserted-by":"crossref","first-page":"ofz089","DOI":"10.1093\/ofid\/ofz089","article-title":"High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis","volume":"6","author":"Leahey","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0012","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00005792-198305000-00004","article-title":"Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts","volume":"62","author":"Chambers","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"2022012912322404400_CIT0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-6-137","article-title":"Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients","volume":"6","author":"Ruotsalainen","year":"2006","journal-title":"BMC Infect Dis"},{"key":"2022012912322404400_CIT0014","doi-asserted-by":"crossref","first-page":"ofz289","DOI":"10.1093\/ofid\/ofz289","article-title":"Disparity in quality of infectious disease vs addiction care among patients with injection drug use\u2013associated Staphylococcus aureus bacteremia","volume":"6","author":"Serota","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0015","first-page":"2112","article-title":"Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States","volume":"69","author":"Inagaki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0016","doi-asserted-by":"crossref","first-page":"e1003247","DOI":"10.1371\/journal.pmed.1003247","article-title":"Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder: a nationwide observational study","volume":"17","author":"Kim","year":"2020","journal-title":"PLoS Med"},{"key":"2022012912322404400_CIT0017","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0018","doi-asserted-by":"crossref","first-page":"ofz028","DOI":"10.1093\/ofid\/ofz028","article-title":"Dalbavancin as secondary therapy for serious Staphylococcus aureus infections in a vulnerable patient population","volume":"6","author":"Bryson-Cahn","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0019","doi-asserted-by":"crossref","first-page":"ofy132","DOI":"10.1093\/ofid\/ofy132","article-title":"Infectious diseases physicians\u2019 perspectives regarding injection drug use and related infections, United States, 2017","volume":"5","author":"Rapoport","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhm.2582","article-title":"Perceptions and practices of physicians regarding outpatient parenteral antibiotic therapy in persons who inject drugs","volume":"11","author":"Fanucchi","year":"2016","journal-title":"J Hosp Med"},{"key":"2022012912322404400_CIT0021","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1093\/infdis\/jiaa024","article-title":"Injection drug use-associated candidemia: incidence, clinical features, and outcomes, East Tennessee, 2014\u20132018","volume":"222","author":"Rossow","year":"2020","journal-title":"J Infect Dis"},{"key":"2022012912322404400_CIT0022","doi-asserted-by":"crossref","first-page":"ofy194","DOI":"10.1093\/ofid\/ofy194","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","volume":"5","author":"Suzuki","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0023","doi-asserted-by":"crossref","first-page":"ofaa162","DOI":"10.1093\/ofid\/ofaa162","article-title":"Home-based outpatient parenteral antibiotic therapy at an urban safety net hospital: comparing outcomes in persons with and without noninjection drug use","volume":"7","author":"Appa","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2022012912322404400_CIT0024","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/jiaa025","article-title":"Feasibility and safety of outpatient parenteral antimicrobial therapy in conjunction with addiction treatment for people who inject drugs","volume":"222","author":"Price","year":"2020","journal-title":"J Infect Dis"},{"key":"2022012912322404400_CIT0025","doi-asserted-by":"crossref","first-page":"e2012974","DOI":"10.1001\/jamanetworkopen.2020.12974","article-title":"Risk of new bloodstream infections and mortality among people who inject drugs with infective endocarditis","volume":"3","author":"Tan","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2022012912322404400_CIT0026","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciaa062","article-title":"Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis","volume":"72","author":"Barocas","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0027","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ajad.13000","article-title":"Impact of medications for opioid use disorder on discharge against medical advice among people who inject drugs hospitalized for infective endocarditis","volume":"29","author":"Suzuki","year":"2020","journal-title":"Am J Addict"},{"key":"2022012912322404400_CIT0028","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study","volume":"41","author":"Simon","year":"2020","journal-title":"Subst Abus"},{"key":"2022012912322404400_CIT0029","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/jiaa012","article-title":"Trends in morbidity, mortality, and cost of hospitalizations associated with infectious disease sequelae of the opioid epidemic","volume":"222","author":"Coyle","year":"2020","journal-title":"J Infect Dis"},{"key":"2022012912322404400_CIT0030","doi-asserted-by":"crossref","first-page":"S458","DOI":"10.1093\/infdis\/jiaa129","article-title":"Not just endocarditis: hospitalizations for selected invasive infections among persons with opioid and stimulant use diagnoses\u2014North Carolina, 2010\u20132018","volume":"222","author":"Sredl","year":"2020","journal-title":"J Infect Dis"},{"key":"2022012912322404400_CIT0031","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1278","article-title":"Evaluating differences in opioid and stimulant use-associated infectious disease hospitalizations in Florida, 2016\u20132017 [manuscript published online ahead of print 4 September 2020]","author":"Serota","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0032","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.4049\/jimmunol.0903691","article-title":"Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment","volume":"185","author":"Potula","year":"2010","journal-title":"J Immunol"},{"key":"2022012912322404400_CIT0033","doi-asserted-by":"crossref","first-page":"e01622-15","DOI":"10.1128\/mBio.01622-15","article-title":"Methamphetamine alters the antimicrobial efficacy of phagocytic cells during methicillin-resistant Staphylococcus aureus skin infection","volume":"6","author":"Mihu","year":"2015","journal-title":"mBio"},{"key":"2022012912322404400_CIT0034","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine\u201425 states, July\u2013December 2017 to January\u2013June 2018","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022012912322404400_CIT0035","doi-asserted-by":"crossref","first-page":"108162","DOI":"10.1016\/j.drugalcdep.2020.108162","article-title":"Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015\u20132018","volume":"214","author":"Shearer","year":"2020","journal-title":"Drug Alcohol Dependence"},{"key":"2022012912322404400_CIT0036","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijantimicag.2011.05.013","article-title":"Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study","volume":"38","author":"Hanberger","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"2022012912322404400_CIT0037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0038","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"2022012912322404400_CIT0039","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"2022012912322404400_CIT0041","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/infdis\/jir275","article-title":"Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet?","volume":"204","author":"Holland","year":"2011","journal-title":"J Infect Dis"},{"key":"2022012912322404400_CIT0042","doi-asserted-by":"crossref","first-page":"e0170236","DOI":"10.1371\/journal.pone.0170236","article-title":"Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality","volume":"12","author":"Bassetti","year":"2017","journal-title":"PLoS One"},{"key":"2022012912322404400_CIT0043","doi-asserted-by":"crossref","first-page":"e01902-17","DOI":"10.1128\/AAC.01902-17","article-title":"Host-pathogen-treatment triad: host factors matter most in methicillin-resistant Staphylococcus aureus bacteremia outcomes","volume":"62","author":"Guillamet","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012912322404400_CIT0044","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"key":"2022012912322404400_CIT0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/318716","article-title":"Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland","volume":"32","author":"Fleisch","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2022012912322404400_CIT0046","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/23744235.2016.1237038","article-title":"Opioid and amphetamine dependence is associated with methicillin-resistant Staphylococcus aureus (MRSA): an epidemiological register study with 73 201 Swedish in- and outpatients 1997\u20132013","volume":"49","author":"Dahlman","year":"2017","journal-title":"Infect Dis"},{"key":"2022012912322404400_CIT0047","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1472-6963-11-105","article-title":"A comparison of comorbidities obtained from hospital administrative data and medical charts in older patients with pneumonia","volume":"11","author":"Chong","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"2022012912322404400_CIT0048","doi-asserted-by":"crossref","first-page":"ofaa414","DOI":"10.1093\/ofid\/ofaa414","article-title":"Use of ICD-10 codes for identification of injection drug use\u2013associated infective endocarditis is nonspecific and obscures critical findings on impact of medications for opioid use disorder","volume":"7","author":"Marks","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab367\/38858982\/ciab367.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/2\/263\/42332214\/ciab367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/74\/2\/263\/42332214\/ciab367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T12:33:20Z","timestamp":1643459600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/74\/2\/263\/6255538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,4,27]]},"published-print":{"date-parts":[[2022,1,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab367","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,15]]},"published":{"date-parts":[[2021,4,27]]}}}